Results 341 to 350 of about 3,376,929 (374)
Some of the next articles are maybe not open access.
Fitness cost of antifungal resistance
Nature Reviews Microbiology, 2022G. Otto
semanticscholar +3 more sources
Resistance to Antifungal Agents
Pediatric Clinics of North America, 1995The marked increase in the number of patients with AIDS and other forms of immunocompromise has resulted in the emergence of fungi as predominant pathogens in many institutions. Unfortunately, with the widespread use of antifungal agents to combat these infections, reports of resistance to antifungal agents have proliferated. In the present environment,
G P, DeMuri, M K, Hostetter
openaire +2 more sources
Update on antifungal resistance
Trends in Microbiology, 1997Overuse of antifungal agents has resulted in the selection of naturally resistant Candida species, as well as expression of resistance from previously susceptible species resulting from genetic mutations and/or selection of resistant subpopulations.
M E, Klepser, E J, Ernst, M A, Pfaller
openaire +2 more sources
Antifungal Drug Resistance in Aspergillus
Journal of Infection, 2000This article overviews the emerging problem of antifungaldrug resistance in Aspergillus. Fluconazole and ketocona-zole (KCZ) are inactive against Aspergillus. Validation oftesting procedures for the detection of itraconazole (ITZ)resistance in Aspergillus fumigatusin 19971,2were furthervalidated with posaconazole (SCH-56592)3,4and voricona-zole (VCZ)5 ...
Moore, C.B. +4 more
openaire +3 more sources
Emerging Issues in Antifungal Resistance
Infectious Disease Clinics of North America, 2020Invasive fungal diseases continue to cause substantial mortality in the enlarging immunocompromised population. It is fortunate that the field has moved past amphotericin B deoxycholate as the only available antifungal drug but despite new classes of antifungal agents both primary and secondary drug resistance in molds and yeasts abound.
John R, Perfect, Mahmoud, Ghannoum
openaire +2 more sources
An update on antifungal resistance in dermatophytosis
Expert Opinion on PharmacotherapyIntroduction The reports of resistance to antifungal agents used for treating onychomycosis and other superficial fungal infections are increasing. This rise in antifungal resistance poses a public health challenge that requires attention.
Aditya K. Gupta +3 more
semanticscholar +1 more source
Medical Mycology, 2021
The emergence of antifungal drug resistance in Candida species has led to increased morbidity and mortality in immunocompromised patients. Understanding species distribution and antifungal drug resistance patterns is an essential step for novel drug ...
Rashi Verma +5 more
semanticscholar +1 more source
The emergence of antifungal drug resistance in Candida species has led to increased morbidity and mortality in immunocompromised patients. Understanding species distribution and antifungal drug resistance patterns is an essential step for novel drug ...
Rashi Verma +5 more
semanticscholar +1 more source
Antifungal resistance in mucorales
International Journal of Antimicrobial Agents, 2017The order Mucorales, which includes the agents of mucormycosis, comprises a large number of species. These fungi are characterised by high-level resistance to most currently available antifungal drugs. Standardised antifungal susceptibility testing methods are now available, allowing a better understanding of the in vitro activity of antifungal drugs ...
openaire +2 more sources
An Overview on Antifungal Resistance
Cuestiones de FisioterapiaFungal infections account for substantial morbidity and mortality worldwide, especially in immunocompromised populations. While antifungal agents such as azoles, echinocandins, and amphotericin B have improved outcomes, increasing resistance among ...
Marwa Nashat Shahin +5 more
semanticscholar +1 more source
Microbial Drug Resistance, 2021
Candida glabrata is the second frequent etiologic agent of mucosal and invasive candidiasis. Based on the recent developments in molecular methods, C. glabrata has been introduced as a complex composed of C.
E. Lotfali +10 more
semanticscholar +1 more source
Candida glabrata is the second frequent etiologic agent of mucosal and invasive candidiasis. Based on the recent developments in molecular methods, C. glabrata has been introduced as a complex composed of C.
E. Lotfali +10 more
semanticscholar +1 more source